Endothelial injury and hypoxia enhances neutrophil recruitment, extravasation, and apoptosis during thrombus formation
TMEM16F-mediated platelet pro-coagulant activity contributes to infarct progression after ischemic stroke
Time-dependent decay of mRNA, ribosomal RNA and translation activity in platelets
Platelets promote MMP-dependent plaque destabilization locally at the site of vascular injury
Genetic or pharmacologic depletion of platelet serotonin attenuates myocardial ischemia reperfusion injury
Lack of endothelial nitric oxide synthase (eNOS) induces a pro-thrombotic phenotype in mice
Microparticles derived from ovarian cancer cell line contained genomic and biologically active proteins, including tissue factor involved in coagulation
Hemostatic disturbances and oxidative stress in experimental Bothrops jararaca envenomation: modulation by the natural antioxidant quercetin-3-rutinoside (Rutin)
Expression of heparanase in cancer as biomarker of malignancies: overexpression in an aggressive, poor survival gastric cancer “gastric signet ring cell carcinoma” compared with that of other gastric cancers
Acquired von willebrand syndrome evoked by experimental Bothrops jararaca envenomation
Patagonfibrase modifies protein expression of tissue factor and protein disulfide isomerase in rat skin
iAlgogenic compounds found in rat platelet releasate
Variegin: pharmacokinetics and pharmacodynamics
Aminoestrogen diebud decreases circulating microparticles
Microfluidic platform for automated endothelial cell culture enabling real time visualisation of blood cell function under flow
Occlusive thrombus growth at high shear rates: comparison of whole blood and platelet rich plasma at constant pressure
Shear-dependent red blood cell and platelet adhesion in sickle cell disease
Clot-bound thrombin under venous flow conditions
Hemorheologic bases for thrombosis in some myeloproliferative neoplasms
Thrombus structure change under various shear rate, using a novel microfluidic device
Effect of extremes of body weight on efficacy and safety of rivaroxaban in the treatment of venous thromboembolism; real life experience
VTE Prevention in Acutely Ill Medical Patients with Extended Duration Betrixaban - A Multicenter, Randomized, Active-Controlled Efficacy and Safety Study Comparing Extended Duration Betrixaban with Standard of Care Enoxaparin
Improving clinical management of VTE: simulation in continuing education
Genetic dosing algorithm underestimates the warfarin dose requirement among patients having severe thrombosis or thrombophilia
Impact of apixaban on the Dilute Russell's viper venom time: an ex-vivo study
Choosing wisely: the impact of inclusion and exclusion criteria on efficacy and safety outcomes in EINSTEINDVT/PE and AMPLIFY
Optimizing therapy for vitamin k antagonist induced major hemorrhage: a systematic review
The effect of andexanet alfa on the pharmacokinetics and renal clearance of the direct factor Xa inhibitors apixaban, rivaroxaban, edodoxaban and betrixaban
Prothrombin conversion and thrombin inactivation in patients anticoagulated with enoxaparin, vitamin K antagonists, and rivaroxaban
Individual variability of plasma with edoxaban on the fibrin structure as a function of blood donors
Accuracy of the louzada prediction rule for recurrent VTE in Cancer patients on rivaroxaban for the treatment of venous thromboembolic disease
Early changes in medication beliefs, illness perceptions and anticoagulation related quality of life in patients poorly controlled on vitamin-K antagonists (VKAs) switched to a direct oral anticoagulant (DOAC) - results from the SWITCHING study
Analysis of heparin induced thrombocytopenia screening tests in critical care units
Post analytical external quality assessment (EQA) for computerised decision support software (CDSS) employed for INR dosing
external quality assurance provision (EQA) for the point of care Xprecia stride INR device
An ultrasound-based sensor for real-time monitoring of heparin anticoagulation therapy
Inclusion of a heparin neutralizer in the plasma diluent confers specificity to the FXa direct oral anticoagulants rivaroxaban, apixaban, and edoxaban in an anti-Xa chromogenic assay
Influence of Factor VII on INR determined with recombinant human and tissue-extract thromboplastins
The effect of dabigatran on thrombin generation in vitro
Commutability of samples used to assess assays for direct oral anticoagulants (DOACS): data from UK NEQAS for blood coagulation multicentre studies
Is the Dilute Russell's viper venom time (DRVV-T) a useful assay for all direct oral anticoagulants (DOACs)?
Outcome of DOAC exposure during pregnancy (…and the problem of event reporting…)
Consequences of warfarin suspension after major bleeding in a cohort of very elderly patients
Assessment of low molecular weight heparin accumulation in patients with chronic kidney disease: results from the TRIVET study
Major bleeding in patients with atrial fibrillation on non vitamin k antagonist oral anticoagulants - data from Ljubljana registry
Patients anticoagulation knowledge (VKA) and INR goal attainment-comparison 2014 and 2016
Can PT, aPTT and TT reliably be used to detect DOAC at clinically relevant concentrations in emergency situations? results from a 660-patient cohort study
Effectiveness of implementing an extended INR testing interval for stable warfarin patients: results from the MAQI2 collaborative of anticoagulation clinics
estimation of rivaroxaban plasma concentrations in the perioperative setting with or without heparin bridging: an ex vivo study using dedicated chromogenic assays
Self-testing and SELF-management of oral anticoagulation therapy (OAT) in children with congenital heart disease (CHD). from the bedside to home. A pilot study in spain
Venous thromboembolism treatment with rivaroxaban in adolescents - preliminary findings from the prospective dresden NOAC registry (NCT01588119)
In vivo and ex vivo effect of various rivaroxaban concentrations on thrombin generation
Evaluation of the CP3000 coagulation analyzer
Evaluation of the intra-, inter- and day-to day variability of the ROTEM®
Quality assurance in a haemostasis laboratory - an evaluation of 7 year quality indicator data utilizing sigma metrics
Propagation of thrombin generation in space reveals difference in effects of heparin, dabigatran and rivaroxaban
A performance evaluation of a novel human recombinant tissue factor prothrombin time reagent
The control of heparin treatment with global hemostasis assays: a sensitivity analysis
Evaluation of laboratoricaly monitored efficiency of new oral anticoagulants rivaroksaban and dabigatran
Measuring direct oral anticoagulants in standardized fully automated thrombin generation on ceveron® alpha
Distinct effects of apixaban and rivaroxaban on thrombin generation and coagulation during recovery after total hip arthroplasty
Performance of a new chromogenic apixaban assay on automated analyzers
Safety and efficacy of dabigatran compared with warfarin in patients with acute venous thromboembolism enrolled in RE-COVER®/RE-COVER IITM in Western Europe
Efficacy and safety of dabigatran vs. warfarin for the treatment of acute venous thromboembolism: a pooled analysis of 90-day data from RE-COVERTM and RE-COVERTM II
Application of basic and special coagulation tests for measuring rivaroxaban activity
EffectiVeness and safety of rivaroxaban therapy in daily-care patients with unusual venous thromboembolism - results of the prospective dresden NOAC registry (NCT01588119)
Reasons and consequences of vitamin K antagonists (VKA) discontinuation in very elderly patients with non valvular atrial fibrillation (NVAF). an inception cohort study
The frequency of gene polymorphism among patients with hemorrhagic complications connected with warfarin therapy
Prescribing errors with new oral anticoagulants at a regional base hospital in NSW, Australia
Comparison of locally measured activated partial thromboplastin time (aPTT) to central laboratory aPTT when measuring reversal of dabigatran using idarucizumab
Warfarin as a new oral anticoagulant agent?
Comparing mechanisms of action of novel anticoagulant reversal agents through studies on binding partners and on clot formation and clot structure
Matrix effect of commercially available direct oral anticoagulant standards: a look through the limits and the need for standardization of current calibrators
Concentration dependent effects of edoxaban on thrombin generation kinetics and physical clot characteristics by TEG 6S and CAT assay
Acute ischemic stroke after administration of kcentra for apixaban- associated Intracranial Hemorrhage
Unusual site thrombosis - epidemiology and outcome
A comparative study using four different clot detection methods for inr monitoring in patients on vitamin k antagonist treatment
Warfarin dose assessment every 4 weeks vs. every 6 to 8 weeks in patients with stable international normalized ratios: a retrospective study
Development of an INRRIVA on plasma samples of patients on rivaroxaban
Length of anti-coagulation in splanchnic venous thrombosis
A different clinical profile of DOAC-treated patients: results from the real life cohort study
Rivaroxaban therapy for patients with pulmonary embolism in real world: a prospective, single center, open-label observation study
Porcine model of methicillin-resistant staphylococcus aureus (MRSA) sepsis-induced disseminated intravascular coagulation (DIC)
Histones released from extracellular nucleosomes upon dnase digestion are rapidly degraded by Factor VII activating protease (FSAP) to combat their cytotoxic effects
Laboratory tests as clues to understand the etiopathogenesis of hemostatic disturbances, acute kidney injury and mild intravascular hemolysis in Bothrops envenomation
Tissue factor initiated thrombin generation in trauma patient plasma
Circulating histone as a marker of cardiovascular failure in patients with sepsis
Coagulopathy assessment in severe sepsis and septic shock patients. an observational pilot study
Coagulation changes in porcine model of sepsis induced by methicillin-resistant staphylococcus aureus (MRSA) inoculation: correlation between ROTEM and routine laboratory tests
Hyaluronic acid decreases the mechanical stability, but increases the lytic resistance of fibrin
Thrombolysis - proteolysis - isopeptidolysis
polyphosphate co-localises with FXII on platelet-bound fibrin and markedly augments αFXIIa-mediated plasminogen activation
Recombinant human ADAMTS13: first-in-human study evaluating pharmacokinetics, safety and tolerability in hTTP patients
The covalent or non-covalent modification of streptokinase with polyethylene glycol improves its properties
Inhibitory effects of intact heavy chain of plasminogen and its fragment K1-4.5 on the generation of plasmin in vitro
The time course of plasma procarboxypeptidase U (proCPU, proCPB2 or TAFI) in traumatic brain injury and aneurysmal subarachnoid hemorrhage is not associated with the presence of acute coagulopathy
Procarboxypeptidase U (proCPU, TAFI, proCPB2) in cerebrospinal fluid (CSF) in the hyperacute phase of ischemic stroke
Local hemostasis changes and endothelial damage during percutaneous transcatheter isolation of the pulmonary veins in patients with atrial fibrillation
Thrombin activatable fibrinolytic inhibitor (TAFI) increases in the plasma of cancer patients with prothrombotic behavior
Combinatorial therapy with C1 esterase inhibitor and tranexamic acid to treat hemorrhagic shock
Effect of elapsed time between plasma separation and processing on fibrinolytic activity
Longitudinal analysis of coagulant and fibrinolytic markers of trauma patients that received tranexamic acid
INSIGHT case-control study: high FVIII concentrate dose and surgery are associated with increased inhibitor risk in nonsevere hemophilia a patients
FVIII-LRP1 interaction affinity is biased by FVIII concentration
Variation in baseline Factor VIII concentration in mild and moderate hemophilia a patients carrying the same F8 mutation
A retrospective study of the current treatment practice of haemophilia A and B in France
Non-neutralizing antibodies against Factor VIII and the risk of inhibitor development in untreated and minimally treated patients with severe hemophilia A (SIPPET study)
Immunological profile of previously untreated patients with haemophilia a: results from the HEMFIL study
Thrombin generation assay (TGA) for monitoring the haemostatic response in patients with hemophilia and inhibitors on immune tolerance induction (ITI): preliminary in vitro and in vivo results from the predicTGA study
Importance of standardized joint-ultrasound for individualization of prophylaxis in hemophiliacs: easy-to-learn-ultrasonography (HEAD-US) of joints and correlation with function in haemophilic arthropathy - results of a clinical trial
Evaluation of the efficiency of immunotolerance in hemophilia a: preliminary results of the Brazilian immmunotolerance study
A novel Factor VIII-nanobody fusion protein displaying prolonged half-life & haemostatic efficacy in vivo
ELISA combined chromogenic assay (ECA) for determination of binding of PEGylated rFVIII to VWF
The patient reported outcome burdens and experiences (PROBE) study - phase 1 results show PROBE study methodology feasible
The relationship between thrombin generation and spontaneous bleeding for hemophilia a subjects in ALONG and extension study
Internal consistency and item-total correlation of patient-reported outcome (PRO) instruments and hemophilia joint health score v2.1 (HJHS) in US adult people with hemophilia (PWH): results from the pain, functional impairment, and quality of life (P-FiQ) study
Known-group validity of patient-reported outcome (PRO) instruments and hemophilia joint health score v2.1 (HJHS) in US adult people with hemophilia (PWH): results from the pain, functional impairment, and quality of life (P-FiQ) study
HLA genotyping and Factor VIII intron 22 inversion in children with severe haemophilia a: relation to Factor VIII inhibitor development
Clinical decision making is effective in reducing bleeding rates without the need to monitor FVIII trough levels tn patients with severe hemophilia a receiving prophylaxis with rVIII-SingleChain
Introduction of a standardised heat inactivated Nijmegen - Bethesda Assay (NBA) for the detection and quantification of FVIII inhibitors
Isolation of antibodies that differentiate between wildtype FIX and the padua variant
Development and application of a FIX-specific immunoassay to monitor hemophilia B gene therapy
Benefit of the study of F8 gene transcription by in vitro, in vivo and in silico analysis in hemophilia A
Method-related potency issues of modified Factor VIII products
Individualizing hemophilia prophylaxis using thromboelastography (HIP TEG)
The frequency and possible reasons of hyperhomocysteinemia in patients with severe haemophilia from North-Western Russia
Product-specific calibration standards do not correct one-stage clotting assay discrepancies for modified recombinant FIX molecules with reagents that significantly over- or under-recover labeled potency
Bleeding scores in hemophilia: are they useful in predicting severity and clinical outcomes
Thrombin generation does not correlate with disease severity but may be predictive of response to treatment in patients with severe hemophilia A
Prophylaxis with factor-eight-inhibitor-by-passingactivity 3 days a week results in safe and effective haemostasis in children with haemophilia a with inhibitors
Results from a world-wide field study of FVIII activity assay variability of BAX 855, the PEGlylated form of rFVIII ADVATE, in clinical hemostasis laboratories
Reagents causing N9-GP underestimation in one-stage FIX clot method inhibit FXIa-catalysed FIX activation and discriminate between N9-GP and FIX in plasma independently of contact activation and phospholipid
Multi-national survey of FVIII activity assay practice
Effects of haemolysis, icterus and lipaemia on coagulation tests as performed using mechanical viscosity based endpoint detection
Mutational anaylysis in 18 Pakistani families with Haemophilia B: identification of a novel mutation
Qualification of selected one-stage APTT and chromogenic assays for the post-administration monitoring of nonacog beta pegol
Diagnosis and management of acquired haemophilia - single centre experience
Turkish experience with low dose of immun tolerance treatment for inhibitor patients
Haemophilia A and immune tolerance induction - our first experiences
N9-GP activity can be measured using select one-stage clot assays and two-stage chromogenic assays in clinical samples from adults/adolescents and children with haemophilia B
Factor VIII effect and sensitivity vary depending on trigger in thrombin generation assays with plasma from patients with hemophilia A
High agreement rate between ellagic acid-based one stage and chromogenic assays for rFVIIIFc post infusion samples in the A-LONG study
A simple predictive model of thrombin generation for the individualization of hemophilic treatment
Effectiveness of heat inactivation in removing residual FVIII interference in the FVIII Nijmegen bethesda assay
Haemolysis effects on clotting factor and thrombotic assay results using matched haemolysed and non-haemolysed patient samples and two artificial haemolysis mechanisms
Application of rox Factor IX on the ACL TOP 700
The utility of ISTH BAT in assessing the bleeding phenotype in patients with FV deficiency
Application of global coagulation assays in hemophilia B patients to evaluate the hemostatic potential in baseline conditions and after FIX concentrate administration
The development of arterial thrombosis in hemophilia A - unusual coincidence? case report and review of the literature
Managing hemophilia treatment in algeria, the experience of constantine
Epidemiological Study of hemophilia at tlemcen university hospital (Algeria)
Potency estimates for recombinant Factor IX in the one-stage clotting assay are influenced by more than just choice of APTT reagent
Calcium chloride reagent regulates thrombin generation response of hemophilia plasma to factor concentrate treatments
Inherited bleeding disorders: an experience from a tertiary care centre in south india with emphasis on an algorithmic approach to diagnosis
A new comprehensive screening program for optimizing the diagnosis of coagulopathies in a tertiary hospital
Distraction arthroplasty in patient with hemophilic arthropathy (a case report)
Novel mechanisms regulating Factor XI plasma levels
Plasma kallikrein contributes to tissue plasminogen activator (tPA) therapy-induced brain injury during thrombotic stroke
Role of plasma kallikrein-kinin system in the pathogenesis of ambient particulate matter-induced lung injury
Assessment of small molecular weight inhibitors of the contact pathway
Copurification of polyphosphate with nucleic acids may contribute to the procoagulant activity of DNA and RNA
Correlation between the thrombogenic Factor XIa and the thrombus score in the venous stasis rabbit model
Procoagulant activity in immunoglobulin products
Investigation of possible correlation between clinical and laboratory phenotype in congenital FXI deficiency: results from a single center
Structure and function consequences of a novel missense mutation in FGB gene (Bbeta Gly272Arg/p.Gly302Arg) Resulting in Afibrinogenemia
Visual quantification of Fibrin network density
Development and evaluation of total and free Factor XIII-B subunit ELISA methods
FXIII activity and antigen during pregancy
Thromboelastography (TEG) and thrombin generation assay (TGA) in congenital Afibrinogenemia
Clinical and molecular characteristics of patients affected by congenital fibrinogen deficiency
Automated fibrin structure assay: determination of normal range
Characterization of phenotypic expression of inherited fibrinogen coagulopathy in Pakistani index patients
Functional/antigen fibrinogen ratio in different clinical situations
Molecular modelling of identified six novel missense mutations in pakistani congenital afibrinogenemia patients
Diagnosis of inherited platelet disorders by a panelbased next generation sequencing approach
Design and application of a twenty-three-gene panel by next-generation sequencing for inherited coagulation bleeding disorders
Utilizing the strength of pedigree-based study design to identify novel tPA Loci
ThromboGenomics: a comprehensive high-throughput sequencing test for the diagnosis of inherited bleeding, thrombotic and platelet disorders
Improved venous thromboembolism risk assessment with a multilocus genetic risk score
Identifying the genetic basis of rare bleeding and platelet phenotypes using systematic phenotyping and genome sequencing
FVII deficiency and thrombosis, coincidence or new mechanism of thrombophilia
Identification of molecular defects in ITGA2B and ITGB3 genes and phenotypic correlation in Pakistani patients with glanzmann thrombasthenia
A novel nonsense mutation Glu326* of PROS1 Leading to ProS Deficiency
Identification of two novel single nucleotide variants of the complement Factor H ( CFH ) and Factor I ( CFI ) genes in a familial form of atypical hemolytic uremic syndrome (aHUS)
High prevalence of VKORC1*3 (G9041A) genetic polymorphism in north indians: a study on patients with cardiac disorders on acenocoumarol
Clinical profile of patients with proximal deep venous thrombosis patients - a prospective observational study from a tertiary care hospital in North India
Aspirin inhibits colon cancer cell proliferation through synergistic suppression of NF- k B and c-MYC oncoproteins
Platelets upregulate c-MYC oncoprotein in pancreatic cancer cells: potential mechanism of platelet-driven neoplastic proliferation
Optimal doses of tinzaparin to reduce both cancerassociated thrombosis and tumor growth in a mouse model of ectopic pancreatic syngeneic tumor
A comparison of cancer types and the epidemiology of first venous thromboembolism in patients with active disease
Fibrin structure assay: a new diagnostic tool in the management of cancer
Thromboembolic events (TE) in patients with metastatic non small cell lung cancer (NSCLC) treated with platinum-based chemotherapy
Cardiovascular effect of BCR-ABL TKIs: a meta-analysis and systematic review of arterial and venous occlusive events
Effects of androgen deprivation therapy on hypercoagulability in prostate cancer patients - a prospective longitudinal study
Diagnostic performance of hemostatic biomarkers iin cancer patients
Evaluation of thromboelastography (TEG) in patients with myeloproliferative neoplasm (MPN): platelet count > 600 associated with prothrombotic parameters
Cancer, Chronic Kidney Disease and Thrombosis
Thromboprophylaxis for prevention of venous thromboembolism in patients with multiple myeloma - a systematic review and metaanalysis
Risk assessment of venous thromboembolism (VTE) and thromboprophylaxis in pregnant women hospitalized with cancer
Tissue factor positive microparticles remain undetectable by flow cytometry in pleural fluids from cancer patients despite high level of procoagulant activity
Microparticle-tissue factor activity as biomarker for excluding thrombosis in acute leukemic patients: comparison of three assays
Short- and long-term mortality after pulmonary embolism in patients with and without cancer
Impedance platelet aggregometry for surveillance of ibrutinib therapy in chronic lymphocytic leukaemia
Platelet transfusion practices in adult surgical, haematology and oncology patients
Platelet-derived factor v is an important determinant of the metastatic potential of circulating tumor cells
The hypercoagulable profile of patients with myeloproliferative neoplasms (MPN) as detected by whole blood rotational thromboelastometry (ROTEM)
Thrombosis in myeloproliferative neoplasia associated with different coagulation factor polymorphisms
Evaluation of mean platelet volume as a predictive marker for venous thromboembolism in patients treated for hodgkin lymphoma
Risk factors assessment for thrombosis in patients with cancer - research project of the federal university of minas gerais
Frequency and management of venous thrombosis in adult acute leukemia patients at a tertiary care hospital of Pakistan
Contribution of modelling of procoagulant properties of cancer cells in the understanding of their mechanisms of action and the effectiveness of anticoagulant agents
Inverted erythrocyte membranes as a novel model for studying the antiphospholipid syndrome
Pravastatin ameliorates preeclampsia and/or severe IUGR in 13 women with refractory obstetric antiphospholipid syndrome (APS)
Mixing test specific cut-off is more sensitive at detecting in vitro lupus anticoagulant inhibition than the index of circulating anticoagulant with multiple APTT and dRVVT reagents
Evaluation of a new formulation dilute russell's viper venom time for detection of lupus anticoagulants
Lupus patients with IgM antiphospholipid antibodies are at risk of thrombocytopenia and haemolytic anemia: pooled results from five systematic reviews and meta-analyses
Use of a lupus anticoagulant-resistant routine APTT reagent as a convenient confirmatory test
Antiphospholipid antibodies in children with immune thrombocytopenic purpura
IgG/IgM antiphospholipid antibodies present in the classification criteria of the antiphospholipid syndrome: a critical review of their association with thrombosis
Detection of anti-domain I beta-2 glycoprotein I antibodies by chemiluminescence immunoassay in antiphospholipid syndrome diagnosis
Study of anti-cardiolipin (IgG/IgM aCL) and antibeta2-glycoprotein I (anti-β2GPI) antibodies in patients with ischemic stroke (Ouest of Algeria)
Bone marrow necrosis and pulmonary thrombosis associated with antiphospholipid syndrome
Factor XIII levels in children with extensive venous malformations and chronic disseminated intravascular coagulation: a single tertiary centre experience
Characterization of laboratory coagulation parameters and risk factors for intraventricular hemorrhage (IVH) in extremely premature neonates
Increased incidence and high recurrence rate of venous thromboembolism in pediatric oncology patients in one single center over 25 years
Central venous catheters and pediatric thromboembolism, a report from the children's hospital acquired thrombosis (CHAT) registry
Six weeks versus 3 months of anticoagulant treatment for paediatric central venous catheter-related venous thromboembolism
Circumcision in children with haemophilia
Pharmacokinetics and pharmacodynamics of singledose oral solution of dabigatran given after standard anticoagulant therapy in children, 2-12 years old, with venous thromboembolism
The incidence of thrombosis and PTS in children 2 years after central venous catheter placement
Body mass index is associated with symptomatic venous thrombotic events in pediatric oncology patients: a study from maritimes, Canada
Catheter-related arterial thrombosis in children: a systematic review
Diagnostic challenges and clinical implications in children with congenital bleeding disorders: a developing country perspective
Risk factors for hospital-associated venous thromboembolism in critically-ill children with cardiac disease undergoing cardiothoracic surgery or cardiac catheter-based therapeutic intervention
Risk factor assignment concordance and clinical care guideline compliance for prevention of pediatric hospital acquired-venous thromboembolism
Paediatric exposure to intravenous unfractionated heparin
Risk factors associated with paediatric thrombosis: a 5 years retrospective analysis in a tertiary care hospital
Endovascular stents in children
Pediatric venous thromboembolism: a single centre experience
Prevalence and characteristics of epistaxis in saudi adolescents
Frequency of Factor V leiden and prothrombin mutation in thrombotic events in children in north moravian region
HIF-2α downregulates tissue factor pathway inhibitor expression in breast cancer
Antithrombin resistance caused by c.1787G>a mutation in prothrombin gene: rare but strong inherited thrombophilia
TFPI levels and correlation with coagulation parameters based on longitudinal observations in healthy subjects
Diagnostic issues in antithrombin, protein C and protein S deficiency in the hungarian population: experience of a large thrombosis laboratory
The performance of thrombin generation assays is compromised at reduced plasma levels of antithrombin III
Latex-based antithrombin antigen assays can give falsely reduced levels
Estimates of within-subject biological variation (CVI) of antithrombin, protein C, Protein S Free and activity, and activated protein C resistance (APCR) during pregnancy
Occurrence of inherited prothrombotic factors, with special reference to genetic alterations in antithrombin III, in North-Indian patients with recurrent pregnancy loss
Associations of elevated FVIII levels and APLAs with APCR-FV Leiden patients with deep vein thrombosis
Identification and significance of anti-MPL autoantibody in immune thrombocytopenia
Decreased miR-142-3p promotes survival of hyperreactive B cells by targeting baff receptorin immune thrombocytopenia
The outcome of eltrombopag therapy in immune thrombocytopenia: a multicenter study from Turkey
Platelet proteomics profiling in transfusion adverse events
Sensitive and specific functional flow cytometry assay for the rapid diagnosis of heparin-induced thrombocytopenia and thrombosis (HIT)
Comparison head-to head of two functional assays in the assessment of heparin-induced thrombocytopenia
Improved regulatory B-cell in adult patients with chronic immune thrombocytopenia treated with rapamycin
Slow responders to Helicobacter pylori eradication in adult japanese patients with immune thrombocytopenia
mTOR staining in bone marrow and spleen tissues of immune thrombocytopenia patients is associated with shorter relapse-free survival
Integrin variations: molecular dynamics and allostery
Can heparin-induced multiple electrode aggregometry improve heparin-induced-thrombocytopenia (HIT) diagnosis in the intensive care unit setting? a prospective study
Very low incidence of heparin-induced thrombocytopenia in pediatric patients, even in those with a high pretest probability
A rapid IgG specific lateral flow immunoassay demonstrates superior diagnostic performance to platelet Factor 4/Heparin-Particle Gel immunoassay in screening for heparin-induced thrombocytopenia
The high frequency of antibodies against the platelet Factor 4/Heparin complex in patients with lung transplantation is not associated with thrombotic events
Clinical significance of low CD4+/CD8+ ratio in patients with immune thrombocytopenic purpura: A single centre study
An activating mutation of DIAPH1 encoding rho-effector diaphanous-related formin-1 causes inherited macrothrombocytopenia associated with sensorineural hearing loss in a french family
Increased platelet expression in HIV positive treatment naive patients does not correlate with CD4 count
Outward migration of procoagulant platelets to thrombus surface is driven by thrombus contraction and decreased adhesivity
Defects in TRPM7 channel function deregulate thrombopoiesis through altered cellular Mg2+ homeostasis and cytoskeletal architecture
Clinical and pathogenetic characterization of ETV6 -related thrombocytopenia ( ETV6 -RT), an inherited thrombocytopenia (IT) predisposing to childhood acute lymphoblastic leukemia (ALL)
PDK1 determines collagen-dependent platelet activation and is critical to development of ischemic stroke in vivo
Three-dimensional electron microscopy reveals new details for platelet granule exocytosis: granule-togranule vs. granule-to-platelet membrane fusion
Blood coagulation factors bound to procoagulant platelets are concentrated in their cap structures to promote clotting
Heat shock protein 70 (Hsp70) regulates platelet integrin activation, granule secretion and aggregation
Severe aortic stenosis-induced platelet activation and high plasma lipoxygenase products are rapidly corrected by transcatheter aortic valve replacement
Risk factors for clopidogrel high on-treatment platelet reactivity in patients with carotid artery stenosis undergoing endarterectomy
Defining the Mac-1 I-domain binding site of the GPIbα N-terminal domain
Platelets are dispensable for antibody-mediated transfusion-related acute lung injury in the mouse
Procoagulant platelets and the role of mitochondria in their formation
Myr-RK6 peptide selectively regulates outside-in signaling transduction-related functions in human platelets
Regulation of αIIbβ3 signalling by the ITIM-containing receptor G6b-B
ABO(H) blood group expression modifies platelet function
Fibrin fibers from cardiovascular disease patients on aspirin are more extensible than fibers from healthy individuals
The impact of CYP2C19 *2, *3, CYP4F2 *3, Fibrinogen β (C-148T) genotype and clinical factors on antiplatelet effect during induction of ticagrelor and aspirin therapy
Development and upscaling of the purification process of snake venom antiplatelet agents
Real time dose adjustment utilizing point of care platelet reactivity testing in a double blind study of prasugrel in children with sickle cell anemia (SCA)
Measurement of platelet serotonin secretion by HPLC-electrochemical detection (ED) in a clinical hemostasis laboratory: sensitive, specific and accurate assay for diagnosing platelet secretion defects and heparin-induced thrombocytopenia
Assessment of platelet function on the routine coagulation analyzer sysmex CS-2000i
Platelet calcium flux measurement by flow cytometry in diluted whole blood
Role of platelets in the spatial clot growth investigated with reaction-diffusion in vitro experimental mode
Psoralen and ultraviolet A light treatment inhibits activation of PI3K dependent effector kinases by disturbing cell membrane packing
Why platelets have two PARs?
Role of formyl peptide receptors in the regulation of thrombosis and haemostasis
Functional and molecular characterization of an inherited abnormal platelet function related to a new Cal-DAG-GEFI protein variant in an argentinean family
Thiol isomerase denitrosylase activity in platelet activation
Value of whole blood impedance aggregometry in the diagnosis of inherited platelet function disorders
Diagnostic value of a flow cytometry based platelet function test compared with light transmission aggregometry in patients with unknown bleeding disorders
Antiplatelet aggregation activity of two schiff base ligands derived from 3-hydroxy-2-naphthaldehyde and their corresponding copper(II) complexes
TPO agonist for the treatment of may hegglin anomaly deriving from MYH9 mutation
In vitro antiplatelet activity of anthocyanin
Sticky platelet syndrome - questionable or independent risk factor for thrombosis?
An atypical IgM antibody that induces integrin αIIbβ3 activation and glanzmann thrombasthenia-like phenotype associated with macrothrombocytopenia
Membrane microvesicles generated in stored blood components
Atabrine binds to the platelet 5HT2A receptor and is not taken up into platelet dense granules
Aspirin Response in Myeloproliferative Patients using Multiplate Aggregometry
Influence of exercise intensity on platelet aggregation in patients with heart disease patients
Platelet function diorders diagnosis using flow cytometry in algeria: about 19 families
Predictors of the secondary aspirin resistance in patients with coronary artery disease over 60 (according to the 10-year follow-up)
Transient impact of treatment exposures and one-year incidence of thrombosis in multiple myeloma: a casetime-control analysis
Acute isolated superficial-vein thrombosis is associated with substantial comorbidity and history of venous thromboembolic complications
Developpment of a new risk assessment model for VTE specific for ambulatory patients with lung adenocarcinoma on chemotherapy. The ROADMAP study
Prevalence of hemostatic defects in dengue hemmorhagic fever in a tertiary care hospital in karachi
Validation of the ISTH-SSC bleeding assessment tool for the diagnosis of inherited bleeding disorders: experience from a tertiary care center in South India
Sub-segmental pulmonary embolism - understanding the clinical significance
Retrievable inferior vena cava filters use in elderly patients
Air pollution and venous thrombosis: a meta-analysis
Acute venous thromboembolism in clinical practice - baseline bleeding risk results from the European PREFER in VTE registry
Ten years of cerebral venous thrombosis (CVT) in Northeast Melbourne, Australia: male gender and presence of myeloproliferative neoplasm is associated with thrombotic recurrence in unprovoked events
Performance of the STA®-Liatest® D-DI plus for the exclusion of pulmonary embolism in emergency departments using an age-adjusted cut-off
D-dimer assay methods state-of-the art from external quality assessment results
Impact of severe ADAMTS-13 deficiency in patients with thrombotic thrombocytopenic purpura (TTP) on recurrences
Description of a new prothrombin gene variant C20214T
Venous Thromboembolism and Variants of FGG, F11 and AB0 in Czech Republic
High sensitive LOCI based F 1 + 2 immunoassay for quantification of prothrombin fragment 1 + 2 in human plasma samples on the new INNOVANCE BCS LT system
Getting the right product to the right patient - proposed platelet concentrate screening to improve transfusion outcome
Evaluation of the risk factors of recurrence of cerebral venous thrombosis
Does thrombin generation test predict the outcome of ischemic stroke after thrombolysis treatment?
An automated indicator for interfering substances in hemostasis
Establishing reference intervals for technothrombin ®TGA based on plasma samples from healthy blood donors
Sudden onset vision loss as an initial manifestation of elevated serum lipoprotein(a) levels
Concerns on reliability of haemostasis activation markers in a cohort of healthy volunteers
Concerns on reliability of haemostasis activation markers in patients with a history of venous thromboembolism
Mean platelet volume as a biomarker of disease activity in polymyalgia rheumatica
Thrombocytopenia and altered coagulation as independent predictors of the etiology of acute undifferentiated febrile illness (AUFI) in adults presenting to emergency in a tertiary care hospital in North India
Red cell distribution width is associated with atherosclerotic cardiovascular mortality in gouty arthritis
Biomarkers of hypercoagulability and clinical variable related with VTE risk in ambulatory patients with lung adenocarcinoma on chemotherapy. The ROADMAP study
Increased mortality associated with omission of venous thrombo-embolism (VTE) prophylaxis in a rural intensive care unit in Victoria, Australia
Thromboelastography and Thrombin Generation Test Follow-Up in Patients Developing Sepsis or Systemic Inflammatory Response Syndrome
Thrombus Formation and Platelet Dynamics Visualization by Multi-scale in vivo 1P, 2P Microscope, and Onchip Imager
Control of protein disulfide isomerase by nitric oxide
CD146 deficiency leads to accelerated atherosclerosis in mice through upregulation of RANTES
SGK1 deficiency protects from neointima formation via reduction of Ca2+-dependent VSMC migration
Lysine-rich histones induce weibel-palade body exocytosis through a calcium, caspase and charge-dependent mechanism
Significant miRNA alterations in human endothelial cells as a result of Staphylococcus aureus infection
Gain-of-function mutation in TRPV4 identified in patients with osteonecrosis of the femoral head
Endothelial cells are important players in the pathogenesis of thrombosis in myeloproliferative neoplasms
Soluble CD146 priming boosts survival and regenerative properties of endothelial colony-forming cells
Activated protein C (APC) down regulates neutrophil extracellular traps (NETs): potential contributing mechanism for anti-inflammatory and antithrombotic effects Of APC
Platelet-derived Factor V Is an important determinant of ischemia-mediated angiogenesis in a mouse hindlimb model
What is the best animal model to specifically target endothelial cells, without concomitant involvement of the hematopoietic lineage?
Gaining insight into the early signals generated in human endothelial cells as a result of bacterial infection
development of a platform to quantify the colocalization of neutrophil extracellular DNA and coagulation factors using immunofluorescence-based microscopy
Platelet function and microparticles levels for patients with paroxysmal and persistent atrial fibrillation including during acute episodes
Biological reference materials to standardize measurements of extracellular vesicles
SIRT1 Deficiency in endothelial progenitor cells drives pro-senescent microparticles release through MKK6 upregulation
Natural killer cells are potent effectors of thromboinflammatory endothelial dysfunction associated with antibody-mediated transplant vasculopathy
Microparticles from acute promyelocytic leukemia generate plasmin in a urokinase-dependent manner
Circulating lipoprotein (a) increases aortic-valve calcification
Association of nitric oxide synthase3 (NOS3) gene polymorphisms with acute myocardial infarction in Indian patients
Endothelial cells response to staphylococcus aureus: critical role of clumping Factor A in sepsis
Acidic preconditioning improves endothelial progenitor cell survival and functionality under inflammatory conditions
Recanalization rates in patients with proximal deep venous thrombosis patients - a prospective observational study from a tertiary care hospital in North India
Application of a clot based assay to measure the procoagulant activity of stored allogeneic red blood cell concentrates
Blood outgrowth endothelial cells from type 3 von willebrand disease patients display abnormal angiogenesis
Inhibition of vWF secretion with novel galpha 12 NTerminal alpha-SNAP binding domain peptide increases survival in septic mice
Role of the arterial pulsatility in the modulation of von willebrand factor multimerisation in an animal model of continuous-flow left ventricular assist support
Possible role of protein disulfide isomerase PDIA in mechanisms of von willebrand disease type 3
Structure and mechanics of von willebrand factor are regulated by pH-dependent interactions in dimeric subunits
Childhood-onset acquired thrombotic thrombocytopenic purpura: the french reference center for thrombotic microangiopathies experience
Clinical-biological-genetic features of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency: the french experience
Platelet-independent binding of activated erythrocytes to von willebrand factor: a pro-active role for erythrocytes in primary hemostasis
TPlatelet type von willebrand disease (PT-VWD) posing diagnostic and therapeutic challenges - small case series
Divergent clinical and laboratory features of acquired VWF abnormalities in patients with pulmonary hypertension vs. high shear cardiac lesions: importance of the procoagulant property of VWF multimers
Severe acquired von willebrand syndrome - a single centre experience
COMPASS-VWF: an international multicenter study to compare VWF activity assays. Report on assay performance
Functional characterization of c.4876instgc and c2555a>g VWF gene variants identified Type 2 VWD patient population in turkey
Inhibition of a mouse-human chimeric monoclonal antibody to von willebrand factor on VWF A3-collagen and VWF A1-platelet interactions
Monoclonal antibody that binds to the C-terminus of the A2 domain of von willebrand factor effectively inhibits platelet adhesion to collagen in a force-dependent manner
Immunohistochemical analysis of von willebrand factor biodistribution in liver endothelial cells
Modification of ADAMTS13 isoforms by estradiol and histamine treatment
HemosIL VWF:RCo® werfen: a more sensitive reagent than the reference technique for the detection of acquired von willebrand disease in thrombocytosis related to myeloproliferative neoplasms
Impact of platelet reactivity on individual thrombin generation in type 3 and 2 von willebrand disease: results from a small prospective study
Clinical evaluation of a new collagen-like protein with von willebrand factor binding activity: toward a New VWF: CBA
Recombinant von willebrand factor kinetics and ultralarge multimer content in severe von willebrand disease patients
Phenotype analysis associated to p.Arg1315Cys (p.R1315C); the value of DDAVP and VWFpp/VWF: Ag ratio to reach the diagnosis
A comparative evaluation of a new fully-automated assay for von willebrand factor collagen binding activity to an established method
Von willebrand factor (VWF) assays and the diagnosis of von willebrand disease (VWD). Who follows the guidelines?
Computer modeling of platelet adhesion to a surface with grafted von willebrand factor multimers
Effects of bilirubin on ADAMTS-13 activity measured with a FRETS rVWF73 substrate-based fluorescent assay
Calibration with the 1st international standard for ADAMTS-13 Using Technozym® ADAMTS-13 activity assay: patient correlation data
Ferritin promotes secretion of von willebrand factor (VWF) from endothelial cells: a potential mechanistic implication for patients with pathological immune activation
Understanding “normal”: baseline VWF characteristics in normal BOECs
ADAMTS13 in chronic liver diseases: data from the developing world
Bleeding score in type 1 von willebrand [VWD] patients using the ISTH-BAT questionnaire
Correlation of phenotypic and genotypic expression of VWD type I and II in Pakistani Patients
Comparison between VWF:RCo and VWF:CB in a 2B VWD cohort
False negative and false positive responses in ristocetin-induced platelet aggregation mixing studies
Phenotype of congenital Factor XIII deficiency in women: report of the French cohort
Abnormal platelet GPIbα and pregnancy outcome: an exploratory study
A meta-analysis of low-molecular-weight heparin to prevent pregnancy loss in women with inherited thrombophilia
Prevention of recurrent pregnancy complications in patients with thrombophilia
Hematologic alterations in patients undergoing controlled ovarian stimulation for in vitro fertilization: a prospective observational pilot study
Sociodemographic characteristics of women with postpartum hemorrhage: a nationwide inpatient sample (NIS)-based analysis
The use of TEG/RoTEM in pregnancy and pregnancy associated complications: results of a worldwide survey by the ISTH SSC for women's health issues in thrombosis and haemostasis
Hyperfibrinolysis as one of the reasons of recurrent fetal loss in the pregnant women
Risk assessment of venous thromboembolism (VTE) and thromboprophylaxis in women hospitalized with multiple pregnancy
Inherited thrombophilia influences localization and extent of pregnancy related deep venous thrombosis
Intravenous iron therapy in non-anemic iron-deficient menstruating adolescent females with fatigue
Thromboelastography in pregnancy: establishing reference ranges in third trimester and exploring predictive value for postpartum haemorrhage
Screening of female family members of von willebrand disease patients: utility of a screening tool
Coagulation factor changes during pregnancy in women with inherited bleeding disorders
Effect of pregnancy on the course of immune thrombocytopenia: a retrospective multicenter study
The clinical presentations and management of hermansky-pudlak syndrome in the obstetric and gynaecology setting - a systemic review
Proposed trial: HYPATIA - a prospective randomised controlled trial of hydroxychoroquine vs. placebo during pregnancy in women with antiphospholipid antibodies
First venous thromboembolic episodes in women with antithrombin deficiency often associated with oral contraceptives or pregnancy
Evaluation of protein c and protein s levels in preeclamptic women seen in a tertiary institution in the niger-delta region of nigeria - any role in the development of preeclampsia?
High Factor VIII and advanced disease are associated with risk of recurrent thrombosis in women with breast cancer
Multicenter registry on thrombophilia and pregnancy loss: the OTTILIA study
Management of pregnancy in vWD patients
The dependence of low molecular weight heparin efficacy (Tested by Anti Xa) on the level of antithrombin - a case report of a pregnant patient with antithrombin defficiency
Yes or no for anticoagulant thromboprophylaxis in pregnant women with repeated pregnancy loss?
The role of LMWH to improve the pregnancy outcome
Antibodies to Factor XII and heterozygous factor V Leiden thrombophilia: are they responsible of intrauterine fetal death in a case of varicella infection during pregnancy?
Absence of pre-operative VWF workup is associated with increased intraoperative bleeding during Wilm's tumor resection
High variation of peri-operative bridging use in realworld practice: results from a clinician survey